131 related articles for article (PubMed ID: 1449351)
1. [Treatment of insulin-dependent diabetes mellitus by insulin pump in children under 7 years of age].
Joseph MG; Ginies JL; Chomienne F; Limal JM
Arch Fr Pediatr; 1992; 49(6):505-10. PubMed ID: 1449351
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
4. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
6. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
7. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
9. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
[TBL] [Abstract][Full Text] [Related]
10. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
[TBL] [Abstract][Full Text] [Related]
11. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
[TBL] [Abstract][Full Text] [Related]
14. Fulfilling the promise of insulin pump therapy in childhood diabetes.
Tamborlane WV
Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of diabetes in children under 3 years of age. Indications, methods and results].
Boselli E; Bougnères PF; Couprie C; Chaussain JL
Arch Fr Pediatr; 1987 Nov; 44(9):759-64. PubMed ID: 3328574
[TBL] [Abstract][Full Text] [Related]
16. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
17. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
18. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
Talaulicar M; Willms B
Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]